Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H513-22. doi: 10.1152/ajpheart.01175.2011. Epub 2012 Jul 9.

Abstract

Acute increases in cellular protein O-linked N-acetyl-glucosamine (O-GlcNAc) modification (O-GlcNAcylation) have been shown to have protective effects in the heart and vasculature. We hypothesized that d-glucosamine (d-GlcN) and Thiamet-G, two agents that increase protein O-GlcNAcylation via different mechanisms, inhibit TNF-α-induced oxidative stress and vascular dysfunction by suppressing inducible nitric oxide (NO) synthase (iNOS) expression. Rat aortic rings were incubated for 3h at 37°C with d-GlcN or its osmotic control l-glucose (l-Glc) or with Thiamet-G or its vehicle control (H(2)O) followed by the addition of TNF-α or vehicle (H(2)O) for 21 h. After incubation, rings were mounted in a myograph to assess arterial reactivity. Twenty-four hours of incubation of aortic rings with TNF-α resulted in 1) a hypocontractility to 60 mM K(+) solution and phenylephrine, 2) blunted endothelium-dependent relaxation responses to ACh and substance P, and 3) unaltered relaxing response to the Ca(2+) ionophore A-23187 and the NO donor sodium nitroprusside compared with aortic rings cultured in the absence of TNF-α. d-GlcN and Thiamet-G pretreatment suppressed the TNF-α-induced hypocontractility and endothelial dysfunction. Total protein O-GlcNAc levels were significantly higher in aortic segments treated with d-GlcN or Thiamet-G compared with controls. Expression of iNOS protein was increased in TNF-α-treated rings, and this was attenuated by pretreatment with either d-GlcN or Thiamet-G. Dense immunostaining for nitrotyrosylated proteins was detected in the endothelium and media of the aortic wall, suggesting enhanced peroxynitrite production by iNOS. These findings demonstrate that acute increases in protein O-GlcNAcylation prevent TNF-α-induced vascular dysfunction, at least in part, via suppression of iNOS expression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylglucosamine / metabolism*
  • Acylation
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / immunology
  • Aorta, Thoracic / metabolism*
  • Aorta, Thoracic / physiopathology
  • Aortic Diseases / immunology
  • Aortic Diseases / metabolism
  • Aortic Diseases / physiopathology
  • Aortic Diseases / prevention & control*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Immunohistochemistry
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Inflammation / physiopathology
  • Inflammation Mediators / metabolism
  • Male
  • Myography
  • Nitric Oxide Synthase Type II / metabolism
  • Oxidative Stress
  • Peroxynitrous Acid / metabolism
  • Protein Processing, Post-Translational*
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Tissue Culture Techniques
  • Tumor Necrosis Factor-alpha / metabolism
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • Vasoconstriction* / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation* / drug effects
  • Vasodilator Agents / pharmacology
  • beta-N-Acetylhexosaminidases / antagonists & inhibitors
  • beta-N-Acetylhexosaminidases / metabolism

Substances

  • Enzyme Inhibitors
  • Inflammation Mediators
  • Tumor Necrosis Factor-alpha
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Peroxynitrous Acid
  • 3-nitrotyrosine
  • Tyrosine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • hexosaminidase C
  • beta-N-Acetylhexosaminidases
  • Acetylglucosamine